NCT05547048 is a Phase 4 clinical trial of Decision Aid in HIV, sponsored by Yale University.

Who is sponsoring NCT05547048?

NCT05547048 is sponsored by Yale University.

What drugs are being tested in NCT05547048?

Interventions in NCT05547048: Decision Aid, Athena strategy.

What condition does NCT05547048 study?

NCT05547048 studies HIV, Opioid Use Disorder, eHealth.

Is NCT05547048 still recruiting?

NCT05547048 is currently recruiting now. Last updated 16 May 2025.

Last reviewed 2025-05-16 · How we verify

NCT05547048

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

Recruiting now Phase 4 Last updated 16 May 2025

What this trial tests

Phase 4 trial testing Decision Aid in HIV in 250 participants. Currently enrolling.

Timeline

25 July 2023

Primary endpoint
1 April 2027

1 April 2027

Quick facts

Lead sponsor	Yale University
Phase	Phase 4
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	250
Start date	25 July 2023
Primary completion	1 April 2027
Estimated completion	1 April 2027
Sites	2 locations across United States

Drugs / interventions tested

Decision Aid
Athena strategy

Conditions studied

HIV — all drugs for HIV →
Opioid Use Disorder — all drugs for Opioid Use Disorder →
eHealth — all drugs for eHealth →

Sponsor

Yale University

Who can join

18 and older, female only, with HIV or Opioid Use Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study.
Meyer JP, Brunson S, Price CR, Mulrain M, et al · · 2025 · cited 2× · PMID 39825419 · DOI 10.1186/s13722-024-00534-x

Verify or expand the search:

Other trials of Decision Aid

Trials testing the same drug.

NCT07536412 — Decision Aid Efficacy in Low Risk Thyroid Cancer · NA · not yet recruiting
NCT06980103 — Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyro · NA · recruiting
NCT06171737 — Promoting Shared Decision Making for Severe Aortic Stenosis · NA · enrolling by invitation
NCT05477420 — Effect of Web-based Decision Aids on Preferences Shift · NA · completed
NCT04777864 — Developing a Tool to Support Shared Decision Making Post-Concussion Between Adolescents, Parents and Clinicians · NA · completed

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05547048 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 16 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05547048.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing